Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study

Rogers, A. V.; Ädelroth, E; Hattotuwa, K.; Dewar, A.; Jeffery, P. K.
February 2008
Thorax;Feb2008, Vol. 63 Issue 2, p108
Academic Journal
Background: Bronchial mucosal dendritic cells (DCs) initiate and regulate immune responses to inhaled antigens, viruses and bacteria. Currently, little is known of their numbers in patients with chronic obstructive pulmonary disease (COPD). While reductions in their numbers have been reported recently in smokers with asthma, nothing is known of the effects of cigarette smoking on bronchial DCs in COPD. The present study compares DC numbers in smokers and ex-smokers with COPD. Methods: Endobronchial biopsies were obtained from 15 patients with moderate to severe COPD (10 current smokers with median forced expiratory volume in 1 s (FEV1) 45.5% predicted (range 23-68) and 5 ex-smokers with median FEV1 30% predicted (range 21-52)), 11 non-smokers with asthma (median FEV1 102% predicted (range 89-116)) and 11 non-smoker healthy controls (median FEV1 110% predicted (range 92-135)). Transmission electron microscopy (TEM) was used to identify the total population of DCs by their ultrastructure and their number in the epithelium and subepithelium was counted. Results: Median (range) DC numbers were significantly lower in current smokers with COPD in the epithelium (0.0 (0.0-156.8) cells/mm2) and the subepithelium (4.5 (0.0-63.6) cells/mm2) compared with ex-smokers with COPD (97.9 (93.5-170.3) cells/mm2 in the epithelium (p<0.05); 91.8 (38.2-283.3) cells/mm2 in the subepithelium (p<0.01)). DC numbers in ex-smokers with COPD were similar to those in subjects with atopic asthma and healthy controls (131.6 (33.3-235.5) cells/mm2 in the epithelium and 64.4 (0.0-182.4) cells/mm2 in the subepithelium for the latter). Conclusions: In COPD, bronchial mucosal DC numbers are lower in current smokers while, in those who quit, numbers are similar to non-smoking subjects with asthma and non-smoking healthy controls. The functional consequences of the reduction in mucosal DC numbers in smokers with COPD have yet to be determined.


Related Articles

  • Isolated Left Upper Lobe Aplasia And Lower Lobe Hypoplasia With Bronchial Asthma. Kushwaha, R. A. S.; Verma, Sanjay Kumar; Mahajan, Vineet; Singh, Ragini; Prasad, R. // Internet Journal of Pulmonary Medicine;2007, Vol. 9 Issue 1, p6 

    Congenital malformations like hypoplasia or aplasia of the lung with bronchial asthma are rare clinical conditions. Here we are reporting such type of case in a 36 years old non smoker male.

  • Smoking, respiratory symptoms and likely asthma in young people: evidence from postal questionnaire surveys in the Wythenshawe Community Asthma Project (WYCAP). Frank, Peter; Morris, Julie; Hazell, Michelle; Linehan, Mary; Frank, Timothy // BMC Pulmonary Medicine;2006, Vol. 6, p10 

    Background: Although it is recognised that smoking is a major risk factor for subjects with chronic obstructive pulmonary disease and is associated with respiratory symptoms, there is less agreement concerning the relationship between asthma and smoking. This study aims to examine the...

  • Is it asthma, COPD, or both? Crockett, Anthony // GP: General Practitioner;5/5/2006, p40 

    The article presents case study of a 79-year-old retired cleaner who smoked 20 cigarettes a day for 25 years before stopping eight years ago. She was chesty as a child but had no problems until a few years ago when she developed gradually worsening breathlessness on exertion with a morning cough...

  • Data reduction for cough studies using distribution of audio frequency content. Barton, Antony; Gaydecki, Patrick; Holt, Kimberley; Smith, Jaclyn A. // Cough (17459974);2012, Vol. 8 Issue 1, p12 

    Background: Recent studies suggest that objectively quantifying coughing in audio recordings offers a novel means to understand coughing and assess treatments. Currently, manual cough counting is the most accurate method for quantifying coughing. However, the demand of manually counting cough...

  • Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Brutsche, M. H.; Downs, S. H.; Schindler, C.; Gerbase, M. W.; Schwartz, J.; Frey, M.; Russi, E. W.; Ackermann-Liebrich, U.; Leuenberger, P. // Thorax;Aug2006, Vol. 61 Issue 8, p671 

    Background: Bronchial hyperrespansiveness (BHR) is a common feature of asthma. However, BHR is also present in asymptomatic individuals and its clinical and prognostic significance is unclear. We hypothesised that BHR might play a role in the development of chronic obstructive pulmonary disease...

  • Smoking Delivers 1-2 Punch: Breathlessness and Immune Deficiency.  // AARC Times;Jul2009, Vol. 33 Issue 7, p177 

    The article discusses research being done on the physiological effect of smoking in patients with chronic obstructive pulmonary disease (COPD). It references a study published in the April 2009 issue of the "American Journal of Respiratory and Critical Care Medicine." Study authors utilized mice...

  • Take a deep breath. Brown, Phyllida // New Scientist;3/27/2004, Vol. 181 Issue 2440, p36 

    Asthma is usually seen as a fairly mild condition whose symptoms can be kept in check with the right medicines. Asthma has long been seen as an intermittent disorder, characterised by temporary bouts of inflammation of the airways, which lead to wheezing, coughing and breathlessness. Only those...

  • COPD in Never Smokers. Kuritzky, Louis // Neurology Alert;Jul2011, Vol. 29 Issue 11, p13 

    The article focuses on research on the impact of chronic obstructive pulmonary disease (COPD) in never smokers conducted by B. Lamprecht and colleagues and published in a 2011 issue of "Chest."

  • From reduced smoking to quitting: improvements in COPD symptoms and lung function: a case report. Fagerström, Karl Olov // Nicotine & Tobacco Research;Feb2001, Vol. 3 Issue 1, p93 

    This case report describes a smoker with chronic obstructive pulmonary disease (COPD) who had given up on trying to stop smoking because of many failed attempts. The patient, a 55-year-old woman, was, however, interested in reducing smoking and harm. During a long reduction phase, aided by...


Read the Article


Sign out of this library

Other Topics